Early treatment of tuberculous uveitis improves visual outcome: a 10-year cohort study
- 114 Downloads
Diagnosis of tuberculous uveitis (TBU) is often challenging and is usually made after excluding other causes of uveitis. We analysed the characteristics of TBU and variables associated with visual outcome.
A retrospective, observational analysis was performed in patients with presumptive TBU who were started on specific TB treatment between January 2006 and June 2016. Demographic, clinical, radiological, analytical and ophthalmic examination variables were studied. After completing TB treatment, a follow-up of at least 9 months was performed. A univariate and logistic regression analysis was applied to identify the variables associated with visual acuity and recurrences of uveitis.
Forty affected eyes of 24 individuals were identified; 79% of patients were diagnosed during the last 3 years of the study period. Median delay from onset of symptoms to diagnosis was 12 weeks. Loss of visual acuity was the most frequent symptom (87.5%). Posterior uveitis was the most frequent localization (72.9%); 19 patients (79.2%) presented at least one of the Gupta signs predictive of TBU, but there were no confirmed diagnoses.
There was improvement in visual acuity in 74.4% of the eyes, but a complete response was achieved only in 56.4%. There was recurrence in two patients. The initiation of treatment ≥ 24 weeks after onset of symptoms was significantly associated with no improvement (p = 0.026).
TBU can cause permanent damage to visual acuity, particularly in patients with delayed diagnosis. A prompt initiation of systemic TB treatment is essential to improve visual prognosis.
KeywordsTuberculosis Uveitis Intraocular tuberculosis
Fundación Galicia Sur Statistics Foundation for statistical support.
Compliance with ethical standards
An institucional Review Board approval was obtained from the Comité Ético de Investigación Galicia Sur (registration code 2017/007.
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
- 6.Levenson JH, Kozarsky K. Visual Acuity. In: Walker HK, Hall WD, Hurst JW, editors. Clinical methods: the history, physical, and laboratory examinations. 3rd ed. Boston: Butterworths; 1990, pp. 563–4.Google Scholar
- 14.Agrawal R, Gunasekeran DV, Grant R, Agarwal A, Kon OM, Nguyen QD, et al. Clinical features and outcomes of patients with tubercular uveitis treated with antitubercular therapy in the collaborative ocular tuberculosis study (COTS)-1. JAMA Ophthalmol. 2017;135:1318–27. https://doi.org/10.1001/jamaophthalmol.2017.4485.CrossRefPubMedGoogle Scholar
- 18.Cordero-Coma M, Garzo I, Salazar R, Franco M, Calleja S, Ruiz de Morales JM. Treatment of presumed tuberculous uveitis affecting the posterior segment: diagnostic confirmation and long term outcomes. Arch Soc Esp Oftalmol. 2013;88:339–44. https://doi.org/10.1016/j.oftal.2012.11.011.CrossRefPubMedGoogle Scholar
- 30.La Distia Nora R, van Velthoven ME, Ten Dam-van Loon NH, Misotten T, Bakker M, van Hagen MP, et al. Clinical manifestations of patients with intraocular inflammation and positive QuantiFERON-TB gold in-tube test in a country nonendemic for tuberculosis. Am J Ophthalmol. 2014;157:754 – 61. https://doi.org/10.1016/j.ajo.2013.11.013.CrossRefPubMedGoogle Scholar